--:-- ET
ETF analysis

ARK Innovation ETF (ARKK) holdings & weights

Per-holding contribution · concentration · sector skew — a deep read

ThematicUS-listed
Annual fee0.75%
Net assets$6.1B
InceptionOct 31, 2014

Fund overview

This is a US-listed ETF from ARK. Key facts — expense ratio 0.75%; net assets about $6.1B; inception Oct 31, 2014. Its 1-year return is -3.27%.

Provider
ARK
Expense ratio
0.75%
Net assets (AUM)
$6.1B
Inception
Oct 31, 2014
1-year return
-3.27%
Holdings
46
52-week range
$62.945–$94.82
Fund details

Fund overview

This is a US-listed ETF from ARK. Key facts — expense ratio 0.75%; net assets about $6.1B; inception Oct 31, 2014. Its 1-year return is -3.27%.

Provider
ARK
Expense ratio
0.75%
Net assets (AUM)
$6.1B
Inception
Oct 31, 2014
1-year return
-3.27%
Holdings
46
52-week range
$62.945–$94.82

45 identified stocks · net exposure / NAV 99.97%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.

Weight and calculation basis

45 identified stocks · net exposure / NAV 99.97%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.

—
Holdings not priced
49.6%
Top-10 weight
379
Concentration HHI (Low)
Health Care
Top sector

We have this ETF's holdings, but the prices for those particular listings are outside our quote coverage (currently Korea- and US-listed securities). So today's contribution and return are not computed — showing 0% would claim it did not move, which is a different statement. The holdings and weights below follow the calculation basis above.

Today's summary

Its top 10 holdings make up about 49.6% of the fund. The concentration index (HHI) is 379 — Low — evenly diversified, and the largest sector is Health Care (26%). The higher the concentration, the more one stock or sector drives the whole ETF's return.

Structural health

A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.

83/ 100
ASimple & diversified
DiversificationHHI 37991

Concentration is below 1,500 (379), so no single holding dominates.

Sector balanceHealth Care 26%98

The largest sector is Health Care at 26% — industries are reasonably spread.

Cost0.75%/yr39

0.75% a year is on the high side — about 7.5% over a decade, so it needs a reason to earn that.

Fund size$6.1B80

Net assets of $6.1B — liquid enough to trade, and unlikely to be wound down.

Structural simplicityPhysical, 1x100

A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.

Concentration and diversification

Structural health

A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.

83/ 100
ASimple & diversified
DiversificationHHI 37991

Concentration is below 1,500 (379), so no single holding dominates.

Sector balanceHealth Care 26%98

The largest sector is Health Care at 26% — industries are reasonably spread.

Cost0.75%/yr39

0.75% a year is on the high side — about 7.5% over a decade, so it needs a reason to earn that.

Fund size$6.1B80

Net assets of $6.1B — liquid enough to trade, and unlikely to be wound down.

Structural simplicityPhysical, 1x100

A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.

Top 20 holdings

Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.

Normalized to 100% of analysed positions

Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.

Tile size = weight, colour = the day's return (deeper = larger). Covers the top 30 holdings, 88.7% of the fund. Labels are dropped where a tile is too small; hover any tile for its name and figures.
#HoldingWeight
1TESLATSLA10.23%
2SPACE EXPLORATION TECHN-CL ASPCX6.48%
3TEMPUS AI-CL ATEM5.14%
4CIRCLE INTERNETCRCL5.11%
5OPENAI PBC SERIES C~OPENAI14.44%
6COINBASE GLOBAL -CLASS ACOIN4.31%
7CRISPR THERAPEUTICSCRSP4.25%
8SHOPIFY -SHOP3.41%
9TWIST BIOSCIENCETWST3.13%
10ROBINHOOD MARKETS - AHOOD3.07%
11NVIDIANVDA3.06%
12PALANTIR TECHNOLOGIES-APLTR2.71%
13COREWEAVE-CL ACRWV2.64%
1410X GENOMICS-CLASS ATXG2.55%
15BEAM THERAPEUTICSBEAM2.45%
16AMAZON.COMAMZN2.42%
17BLOCKXYZ2.41%
18INTELLIA THERAPEUTICSNTLA2.07%
19META PLATFORMS-CLASS AMETA2.06%
20BROADCOMAVGO1.89%

Holdings below 0.5% or outside the top list are folded into “Others” and omitted above.

Where the weight sits — sector mix

Listed equity weights summed by sector and normalized to 100%. Each band is one sector's share.

Health Care26.1%
Information Technology23.4%
Financials19.0%
Consumer Discretionary16.1%
Unclassified6.7%
Industrials5.4%
Communication Services3.4%
Industry breakdown
Computer Software: Programming Data Processing15.0%
Finance: Consumer Services13.5%
Computer Software: Prepackaged Software12.3%
Biotechnology: Biological Products (No Diagnostic Substances)11.2%
Auto Manufacturing10.2%
Semiconductors9.5%
Unclassified6.7%
Medical Specialities3.2%
Investment Bankers/Brokers/Service3.1%
Biotechnology: Laboratory Analytical Instruments2.9%
Catalog/Specialty Distribution2.4%
Military/Government/Technical2.2%
Biotechnology: In Vitro & In Vivo Diagnostic Substances2.1%
Industrial Machinery/Components1.0%
Medical/Nursing Services1.0%
Aerospace1.0%
Semiconductor Equipment0.9%
Metal Fabrications0.8%
Biotechnology: Pharmaceutical Preparations0.6%
Medical/Dental Instruments0.3%
Concentration at a glanceHHI 379well spread
spread1,0001,8002,500concentrated

HHI sums the squared weights. The more it leans on a few names, the higher it goes — and the more the whole ETF moves with them.

How concentrated is it

Concentration (HHI) is low at 379, with the top 10 holdings at just 49.6% of equity weight. No single name can dominate the fund.

Good for damping single-stock risk — and equally, a big winner inside gets diluted.

HHI squares each weight and sums them: 10,000 means one stock is everything, and the more evenly spread the holdings, the closer it falls to zero.

Where the sector weight sits

Sectors run Health Care(26%) · Information Technology(23%) · Financials(19%), and even the largest is only 26% — no meaningful industry tilt.

This is built to track a market rather than to call a sector.

Weights above sum the individually listed equities and normalize that equity total to 100%.

How much it overlaps others

It shares 54% of its holdings with ARKW (20 names in common) — close to half the same companies.

Own both and the diversification is thinner than it looks.

What it is made of

The fund holds 46 positions in total; this page lists the largest 45 and folds the rest into "Others".

The expense ratio is 0.75% a year, which is not cheap. Fees come out of returns every year you hold, so it is worth checking whether the same index is available for less.

This page is not investment advice. Investment decisions and responsibility are your own.

ARKK comments

Leave a one-line take on ARK Innovation ETF. No account — just a nickname and a code to delete it later.

Loading…

Similar ETFs

Picked by how much their actual holdings overlap. The higher the overlap, the less diversification you get from owning both.